glp 1 results before and after Effective GLP-1 Weight Loss GLP-1 Medications: The New Weight

71% reported lack of adequate patient education as the top concern followed by improper patient monitoring (65%) and lack of familiarity with side effects (52%)

Lost 3.1% body weight (6.5 lbs) during program, below the 5% clinical threshold

They produce the alpha-melanocyte stimulating hormone (alpha-MSH) that binds to the melanocortin 3 and 4 receptors (MC3Rs and MC4Rs) expressed by the second order neurons located in the periventricular nucleus and the lateral hypothalamic area (LHA) (51) (Figure 1)

There are several different GLP-1 receptor agonists approved for the treatment of Type 2 diabetes

Wegovy (higher doses, up to 2.4mg) is approved specifically for weight loss

WeGovy WeGovy, produced by Novo Nordisk, is the older of the second generation incretins containing Semaglutide